Search research articles
Contact Us
Filters
Showing results (501-510 of 1,050) with videos related to
Page
of 105
Sort By:
The Journal of Pharmacy and Pharmacology
|
June 1, 1980
Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations
A E Theodorou, M D Hall, P Jenner, et al.
Experimental Brain Research
|
January 1, 1986
Effects of somatostatin on dopamine sensitive adenylate cyclase activity in the caudate-putamen of the rat
A Moser, C Reavill, P Jenner, et al.
British Journal of Pharmacology
|
October 1, 1975
Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway
B Costall, C D Marsden, R J Naylor, et al.
British Journal of Pharmacology
|
March 1, 1977
Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings]
A C Dolphin, P Jenner, C D Marsden, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1995
Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease
O Bandmann, M B Davis, C D Marsden, et al.
Brain : a Journal of Neurology
|
September 1, 1977
The effect of lesions of the sensorimotor cortex and the capsular pathways on servo responses from the human long thumb flexor
C D Marsden, P A Merton, H B Morton, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1994
The syndrome of painful legs and moving toes
D Dressler, P D Thompson, R F Gledhill, et al.
Biochemical Pharmacology
|
September 1, 1983
Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake
K Murugaiah, S Fleminger, A Theodorou, et al.
Acta Neurologica Scandinavica
|
December 1, 1980
Lisuride in the treatment of Parkinsonism
M Schachter, M P Sheehy, J D Parkes, et al.
European Journal of Pharmacology
|
December 30, 1996
Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics
M J Hurley, C M Stubbs, P Jenner, et al.
Page
of 105
Search research articles
Search
Showing results (501-510 of 1,050) with videos related to
Sort By:
Page
of 105
The Journal of Pharmacy and Pharmacology
|
June 1, 1980
Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations
A E Theodorou, M D Hall, P Jenner, et al.
Experimental Brain Research
|
January 1, 1986
Effects of somatostatin on dopamine sensitive adenylate cyclase activity in the caudate-putamen of the rat
A Moser, C Reavill, P Jenner, et al.
British Journal of Pharmacology
|
October 1, 1975
Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway
B Costall, C D Marsden, R J Naylor, et al.
British Journal of Pharmacology
|
March 1, 1977
Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings]
A C Dolphin, P Jenner, C D Marsden, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1995
Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease
O Bandmann, M B Davis, C D Marsden, et al.
Brain : a Journal of Neurology
|
September 1, 1977
The effect of lesions of the sensorimotor cortex and the capsular pathways on servo responses from the human long thumb flexor
C D Marsden, P A Merton, H B Morton, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1994
The syndrome of painful legs and moving toes
D Dressler, P D Thompson, R F Gledhill, et al.
Biochemical Pharmacology
|
September 1, 1983
Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake
K Murugaiah, S Fleminger, A Theodorou, et al.
Acta Neurologica Scandinavica
|
December 1, 1980
Lisuride in the treatment of Parkinsonism
M Schachter, M P Sheehy, J D Parkes, et al.
European Journal of Pharmacology
|
December 30, 1996
Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics
M J Hurley, C M Stubbs, P Jenner, et al.
Page
of 105